Newbridge Financial Services Group, Inc. - ALX ONCOLOGY HLDGS INC ownership

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$106
-35.8%
220.0%0.00%
Q2 2023$165
+66.7%
220.0%0.00%
Q1 2023$99
-60.1%
220.0%0.00%
Q4 2022$248220.0%0.00%
Q3 2022$0220.0%0.00%
Q2 2022$0220.0%0.00%
Q1 2022$0220.0%0.00%
Q4 2021$0
-100.0%
220.0%0.00%
-100.0%
Q3 2021$2,000
+100.0%
220.0%0.00%0.0%
Q2 2021$1,000
-50.0%
220.0%0.00%0.0%
Q1 2021$2,000220.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q2 2021
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$530,392,00062.60%
Logos Global Management LP 3,156,981$172,624,00014.51%
Vivo Capital, LLC 4,220,048$230,752,0009.99%
Foresite Capital Management V, LLC 231,200$12,642,0004.97%
Cormorant Asset Management, LP 889,454$48,635,0001.65%
Board of Trustees of The Leland Stanford Junior University 259,982$14,216,0001.33%
Redmile Group, LLC 914,035$49,979,0000.74%
SPHERA FUNDS MANAGEMENT LTD. 192,728$10,538,0000.71%
Financial Advisory Group 54,041$2,955,0000.71%
Nan Fung Group Holdings Ltd 34,950$1,911,0000.59%
View complete list of ALX ONCOLOGY HLDGS INC shareholders